JPMorgan’s chief executive, Jamie Dimon, cautioned investors that the current boom in asset prices and high borrowing could trigger a crisis similar to 2008. He warned that banks taking on risky loans and the excitement around artificial intelligence are signs of a fragile system. Dimon compar
Markisha Marie Williams grew up in East Tremont, dreaming of shoes that sparkle. Now, at 34, she runs a brand called M. Marie that has caught the eye of New York’s style crowd and even celebrities. Her new line, “Diamonds are Forever, ” drops in March. Williams says she always knew shoes were
A new learning hub is opening its doors for kids in Ogle and Lee counties who need a different classroom vibe. The place is called the Chana Education Center, and it’s built to help students who face anxiety, trauma, or learning differences thrive. Instead of a huge lecture hall, Chana offers a t
Mice were trained to decide whether a picture meant “go” or “no‑go. ” Scientists recorded the electrical activity of single neurons in ten brain areas for weeks. They used ultra‑flexible wires that stayed attached to the mice’s heads, so they could watch how each region talked to the others du
Angelini Pharma and Quiver Bioscience have joined forces to look for new medicines that could help children suffering from hard‑to‑treat genetic epilepsies. The deal gives Quiver a chance to use Angelini’s long experience in brain drugs while Angelini gains access to Quiver’s cutting‑edge AI tools a
The U. S. ambassador to NATO, Matthew Whitaker, told a Washington broadcast that Europe’s relaxed stance after the Soviet collapse is now at odds with the reality of war in Ukraine. He said European leaders are not worried about U. S. support, but rather the growing danger on their own continent as
A leading health news site has earned a top journalism prize for its coverage of the changes in federal health policy under the last U. S. president. The award highlighted stories that traced how the Food and Drug Administration was reshaped, how scientific research funding shifted, and what these m
The world of neural biomaterials has seen big changes over the past 25 years. New tools and methods have popped up to tackle issues in the spinal cord and nerves. This journey mirrors the work of a key researcher in the field. The last few decades have brought some major breakthroughs. These advanc
Klebsiella pneumoniae is a sneaky bacteria that's become a big problem worldwide. It's resistant to many antibiotics, and the situation is getting worse. One of the few antibiotics that still works is cefiderocol, but even that's not foolproof. Some strains of Klebsiella pneumoniae, especially those
Multiple sclerosis is a disease that damages the brain and spinal cord. It usually shows up in young people, but many low‑income countries miss it or treat it poorly. In Nepal, doctors and the public often do not know enough about the condition. People also struggle to get brain scans, lab tests,
